Teladoc Health Inc. (NYSE: TDOC) stock plummeted 5.05% in pre-market trading on Friday, as the company's widening losses overshadowed its in-line earnings performance for the full year 2024.
The virtual healthcare provider reported a net loss of $1.0 billion for the year, a staggering 354% increase from the previous year. Earnings per share deteriorated to a loss of $5.87, compared to a loss of $1.34 in 2023. Despite the mounting losses, Teladoc's revenue of $2.57 billion was in line with analyst estimates, though it declined 1.3% year-over-year.
The Integrated Care segment remained the primary revenue driver, contributing $1.53 billion (59% of total revenue). However, Teladoc's sales and marketing costs also ballooned to $910.8 million, accounting for a significant 32% of total expenses. Looking ahead, the company's revenue growth is projected to remain flat over the next three years, lagging behind the 9.6% growth forecast for the overall healthcare services industry in the US.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.